RA
At a glance
Registered since
2024
Senate LDA system
Clients
6
last 3 years
Filings
18
4 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Chief Health Counsel for Chairman - House E&C Committee (E&C);Counsel - E&C
Clerk - E&C, and Paid Intern - E&C
Disclosed on LD-2 filings
Chief Health Counsel for Chair - House E&C Committee (E&C); Counsel - E&C; Clerk - E&C; and paid Intern - E&C
Disclosed on LD-2 filings
Chief Health Counsel for Chairman - House Energy and Commerce Committee (E&C); Counsel - E&C; Clerk - E&C; Paid Intern - E&C
Disclosed on LD-2 filings
Career
LP
Specific issues
Work with Congress and the Administration to expand Medicaid coverage of whole genome sequencing for children with rare diseases.
Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded so long as their FDA approved uses are exclusively for rare diseases.
Improvements to the 340B drug discount program.
Advocating for federal health care policies based on the National Academies 2020 report that will improve the lives of patients living with Sickle Cell Disease.
-330 Funding -Health Care Workforce Issues -Program for All-Inclusive Care for the Elderly
Pharmaceutical and patient safety issues.
Clients
Filing history
GENOMIC ANSWERS FOR CHILDRENS HEALTH ALLIANCE (GACHA)
ALTAMED HEALTH SERVICES CORPORATION
SAVE RARE TREATMENTS TASK FORCE
SICKLE CELL DISEASE PARTNERSHIP
340B WORKING TABLE
GENOMIC ANSWERS FOR CHILDRENS HEALTH ALLIANCE (GACHA)
BAXTER HEALTHCARE
GENOMIC ANSWERS FOR CHILDRENS HEALTH ALLIANCE (GACHA)
SAVE RARE TREATMENTS TASK FORCE
SICKLE CELL DISEASE PARTNERSHIP
BAXTER HEALTHCARE
340B WORKING TABLE